{"id":"https://openalex.org/W2124842297","doi":"https://doi.org/10.1093/jjco/hyu046","title":"The Drug Discovery by NanoMedicine and its Clinical Experience","display_name":"The Drug Discovery by NanoMedicine and its Clinical Experience","alternate_titles":[],"publication_year":2014,"publication_date":"2014-04-21","ids":{"openalex":"https://openalex.org/W2124842297","doi":"https://doi.org/10.1093/jjco/hyu046","mag":"2124842297","pmid":"https://pubmed.ncbi.nlm.nih.gov/24755547"},"language":"en","primary_location":{"id":"doi:10.1093/jjco/hyu046","doi":"https://doi.org/10.1093/jjco/hyu046","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jjco/hyu046","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2124842297"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028273614","display_name":"Yasuhiro Matsumura","orcid":"https://orcid.org/0000-0003-4331-8177","observed_orcids":["https://orcid.org/0000-0003-4331-8177"]},"institutions":[{"id":"https://openalex.org/I4210087348","display_name":"National Cancer Centre Japan","ror":"https://ror.org/0025ww868","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210087348"]},{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yasuhiro Matsumura","raw_affiliation_strings":["Division of Developmental Therapeutics, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Japan yhmatsum@east.ncc.go.jp","Division of Developmental Therapeutics, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Developmental Therapeutics, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Japan yhmatsum@east.ncc.go.jp","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4210145079"]},{"raw_affiliation_string":"Division of Developmental Therapeutics, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa, Japan","institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4210145079"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028273614"],"corresponding_institution_ids":["https://openalex.org/I4210087348","https://openalex.org/I4210145079"],"apc_list":{"value":3604,"currency":"USD","value_usd":3604},"apc_paid":null,"fwci":1.0274,"has_fulltext":true,"cited_by_count":89,"citation_normalized_percentile":{"value":0.69965278,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":100},"biblio":{"volume":"44","issue":"6","first_page":"515","last_page":"525"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nanomedicine","display_name":"nanomedicine","score":0.7680000066757202},{"id":"https://openalex.org/keywords/anticancer-drug-delivery","display_name":"anticancer drug delivery","score":0.8090000152587891},{"id":"https://openalex.org/keywords/micelles","display_name":"micelles","score":0.6330000162124634},{"id":"https://openalex.org/keywords/liposomes","display_name":"liposomes","score":0.9980000257492065},{"id":"https://openalex.org/keywords/enhanced-permeability-and-retention-effect","display_name":"enhanced permeability and retention effect","score":0.8799999952316284},{"id":"https://openalex.org/keywords/polyethylene-glycol","display_name":"polyethylene glycol","score":0.7570000290870667},{"id":"https://openalex.org/keywords/reticuloendothelial-system-evasion","display_name":"reticuloendothelial system evasion","score":0.7910000085830688},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9359999895095825},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9850000143051147},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.9490000009536743},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.5270000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7807914614677429},{"id":"https://openalex.org/C15083742","wikidata":"https://www.wikidata.org/wiki/Q261659","display_name":"Nanomedicine","level":3,"score":0.646033763885498},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6147037148475647},{"id":"https://openalex.org/C11268172","wikidata":"https://www.wikidata.org/wiki/Q421110","display_name":"Micelle","level":3,"score":0.5909212231636047},{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.559120774269104},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.529691755771637},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4906848669052124},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.48659956455230713},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.45250049233436584},{"id":"https://openalex.org/C13245373","wikidata":"https://www.wikidata.org/wiki/Q3715494","display_name":"Drug carrier","level":3,"score":0.45062971115112305},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3125949800014496},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.30076783895492554},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.21899673342704773},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.20163002610206604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18341541290283203},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09378525614738464},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.08288830518722534},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C184651966","wikidata":"https://www.wikidata.org/wiki/Q906356","display_name":"Aqueous solution","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002851","descriptor_name":"Chromatography, High Pressure Liquid","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008401","descriptor_name":"Gas Chromatography-Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008823","descriptor_name":"Micelles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009374","descriptor_name":"Neoplasms, Experimental","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011099","descriptor_name":"Polyglutamic Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011099","descriptor_name":"Polyglutamic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D011506","descriptor_name":"Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013058","descriptor_name":"Mass Spectrometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D050997","descriptor_name":"Nanomedicine","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":true},{"descriptor_ui":"D053758","descriptor_name":"Nanoparticles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/jjco/hyu046","doi":"https://doi.org/10.1093/jjco/hyu046","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jjco/hyu046","pdf_url":null,"source":{"id":"https://openalex.org/S149902429","display_name":"Japanese Journal of Clinical Oncology","issn_l":"0368-2811","issn":["0368-2811","1465-3621"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:24755547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24755547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Japanese journal of clinical oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W335570002","https://openalex.org/W1497490920","https://openalex.org/W1516766157","https://openalex.org/W1539571840","https://openalex.org/W1592797175","https://openalex.org/W1679811816","https://openalex.org/W1871308790","https://openalex.org/W1899397722","https://openalex.org/W1935541780","https://openalex.org/W1963527493","https://openalex.org/W1972286977","https://openalex.org/W1974920077","https://openalex.org/W1975154077","https://openalex.org/W1975316159","https://openalex.org/W1975580277","https://openalex.org/W1977553393","https://openalex.org/W1989109875","https://openalex.org/W1990869510","https://openalex.org/W1991940265","https://openalex.org/W1994584379","https://openalex.org/W1998713301","https://openalex.org/W2014668585","https://openalex.org/W2018604197","https://openalex.org/W2024013355","https://openalex.org/W2024787650","https://openalex.org/W2024789639","https://openalex.org/W2024873626","https://openalex.org/W2030855909","https://openalex.org/W2032760352","https://openalex.org/W2046289817","https://openalex.org/W2049293202","https://openalex.org/W2049432837","https://openalex.org/W2054288621","https://openalex.org/W2062594120","https://openalex.org/W2067405326","https://openalex.org/W2071108198","https://openalex.org/W2079142824","https://openalex.org/W2079571567","https://openalex.org/W2083349615","https://openalex.org/W2083710155","https://openalex.org/W2084923285","https://openalex.org/W2085122193","https://openalex.org/W2086584469","https://openalex.org/W2099703857","https://openalex.org/W2102551452","https://openalex.org/W2112927879","https://openalex.org/W2113919377","https://openalex.org/W2116150122","https://openalex.org/W2117239059","https://openalex.org/W2125052019","https://openalex.org/W2127232551","https://openalex.org/W2128328462","https://openalex.org/W2129727563","https://openalex.org/W2131748114","https://openalex.org/W2134427544","https://openalex.org/W2135578643","https://openalex.org/W2143219457","https://openalex.org/W2153017356","https://openalex.org/W2153957030","https://openalex.org/W2156836759","https://openalex.org/W2159905203","https://openalex.org/W2162351643","https://openalex.org/W2165836181","https://openalex.org/W2314203153","https://openalex.org/W2331162446","https://openalex.org/W2441940877","https://openalex.org/W4244122029"],"related_works":["https://openalex.org/W2462130392","https://openalex.org/W2158483050","https://openalex.org/W2153957030","https://openalex.org/W2063414742","https://openalex.org/W2999578670","https://openalex.org/W22471006","https://openalex.org/W2312295095","https://openalex.org/W2202783213","https://openalex.org/W2416459371"],"abstract_inverted_index":{"It":[0],"is":[1,47,132],"expected":[2],"that":[3],"the":[4,17,37,41,45,53,67,153],"incidence":[5],"of":[6,10,44,97,100,126,142,155],"various":[7],"adverse":[8],"effects":[9],"anticancer":[11,75,101],"agents":[12],"maybe":[13],"decreased":[14],"owing":[15],"to":[16,62],"reduced":[18],"drug":[19,86],"distribution":[20],"in":[21,115,119],"normal":[22],"tissue.":[23],"Anticancer":[24],"agent":[25,102],"incorporating":[26,103,130,146,150],"nanoparticles":[27,46,161],"including":[28],"micelles":[29],"and":[30,55,70,82,139,152,162],"liposomes":[31],"can":[32,58],"evade":[33],"non-specific":[34],"capture":[35],"by":[36,65],"reticuloendothelial":[38],"system":[39,88],"because":[40],"outer":[42],"shell":[43],"covered":[48],"with":[49],"polyethylene":[50],"glycol.":[51],"Consequently,":[52],"micellar":[54],"liposomal":[56],"carrier":[57,105],"be":[59],"delivered":[60],"selectively":[61],"a":[63,95,128],"tumor":[64],"utilizing":[66],"enhanced":[68],"permeability":[69],"retention":[71],"effect.":[72],"Presently,":[73],"several":[74,107],"agent-incorporating":[76],"nano-carrier":[77],"systems":[78],"are":[79,110,170],"under":[80],"preclinical":[81,138],"clinical":[83,98,108,140],"evaluation.":[84],"Several":[85],"delivery":[87],"formulations":[89],"have":[90],"been":[91],"approved":[92],"worldwide.":[93],"Regarding":[94],"pipeline":[96],"development":[99],"micelle":[104,131,151],"system,":[106],"trials":[109],"now":[111,133],"underway":[112],"not":[113],"only":[114],"Japan":[116],"but":[117],"also":[118],"other":[120],"countries.":[121],"A":[122],"Phase":[123],"3":[124],"trial":[125],"NK105,":[127,143],"paclitaxel":[129],"underway.":[134],"In":[135],"this":[136],"paper,":[137],"studies":[141],"NC-6004,":[144],"cisplatin":[145],"micelle,":[147],"NC-6300,":[148],"epirubicin":[149],"concept":[154],"cancer":[156,166],"stromal":[157,168],"targeting":[158],"therapy":[159],"using":[160],"monoclonal":[163],"antibodies":[164],"against":[165],"related":[167],"components":[169],"reviewed.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2124842297","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":16},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":10}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
